MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Viking Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-12 4:26 pm Sale |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
MILLENNIUM MANAGEMENT LLC | 403,556 0.400% |
-4,425,644 (-91.64%) |
Filing |
| 2023-01-03 4:51 pm Purchase |
2022-12-23 | 13G | Viking Therapeutics, Inc. VKTX |
MILLENNIUM MANAGEMENT LLC | 4,829,200 6.300% |
4,829,200 (New Position) |
Filing |